Global Chronic Myeloid Leukemia Treatment Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Chronic Myeloid Leukemia Treatment by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Chronic Myeloid Leukemia Treatment by Country/Region, 2017, 2022 & 2028

2.2 Chronic Myeloid Leukemia Treatment Segment by Type

2.2.1 Tablet

2.2.2 Solution

2.2.3 Capsule

2.3 Chronic Myeloid Leukemia Treatment Sales by Type

2.3.1 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

2.3.2 Global Chronic Myeloid Leukemia Treatment Revenue and Market Share by Type (2017-2022)

2.3.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Type (2017-2022)

2.4 Chronic Myeloid Leukemia Treatment Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Chronic Myeloid Leukemia Treatment Sales by Application

2.5.1 Global Chronic Myeloid Leukemia Treatment Sale Market Share by Application (2017-2022)

2.5.2 Global Chronic Myeloid Leukemia Treatment Revenue and Market Share by Application (2017-2022)

2.5.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Application (2017-2022)

3 Global Chronic Myeloid Leukemia Treatment by Company

3.1 Global Chronic Myeloid Leukemia Treatment Breakdown Data by Company

3.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Company (2020-2022)

3.1.2 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Company (2020-2022)

3.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Company (2020-2022)

3.2.1 Global Chronic Myeloid Leukemia Treatment Revenue by Company (2020-2022)

3.2.2 Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company (2020-2022)

3.3 Global Chronic Myeloid Leukemia Treatment Sale Price by Company

3.4 Key Manufacturers Chronic Myeloid Leukemia Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Chronic Myeloid Leukemia Treatment Product Location Distribution

3.4.2 Players Chronic Myeloid Leukemia Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chronic Myeloid Leukemia Treatment by Geographic Region

4.1 World Historic Chronic Myeloid Leukemia Treatment Market Size by Geographic Region (2017-2022)

4.1.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Geographic Region

4.2 World Historic Chronic Myeloid Leukemia Treatment Market Size by Country/Region (2017-2022)

4.2.1 Global Chronic Myeloid Leukemia Treatment Annual Sales by Country/Region (2017-2022)

4.2.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue by Country/Region

4.3 Americas Chronic Myeloid Leukemia Treatment Sales Growth

4.4 APAC Chronic Myeloid Leukemia Treatment Sales Growth

4.5 Europe Chronic Myeloid Leukemia Treatment Sales Growth

4.6 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Growth

5 Americas

5.1 Americas Chronic Myeloid Leukemia Treatment Sales by Country

5.1.1 Americas Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)

5.1.2 Americas Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)

5.2 Americas Chronic Myeloid Leukemia Treatment Sales by Type

5.3 Americas Chronic Myeloid Leukemia Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chronic Myeloid Leukemia Treatment Sales by Region

6.1.1 APAC Chronic Myeloid Leukemia Treatment Sales by Region (2017-2022)

6.1.2 APAC Chronic Myeloid Leukemia Treatment Revenue by Region (2017-2022)

6.2 APAC Chronic Myeloid Leukemia Treatment Sales by Type

6.3 APAC Chronic Myeloid Leukemia Treatment Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Chronic Myeloid Leukemia Treatment by Country

7.1.1 Europe Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)

7.1.2 Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)

7.2 Europe Chronic Myeloid Leukemia Treatment Sales by Type

7.3 Europe Chronic Myeloid Leukemia Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chronic Myeloid Leukemia Treatment by Country

8.1.1 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022)

8.1.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022)

8.2 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Type

8.3 Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment

10.3 Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment

10.4 Industry Chain Structure of Chronic Myeloid Leukemia Treatment

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Chronic Myeloid Leukemia Treatment Distributors

11.3 Chronic Myeloid Leukemia Treatment Customer

12 World Forecast Review for Chronic Myeloid Leukemia Treatment by Geographic Region

12.1 Global Chronic Myeloid Leukemia Treatment Market Size Forecast by Region

12.1.1 Global Chronic Myeloid Leukemia Treatment Forecast by Region (2023-2028)

12.1.2 Global Chronic Myeloid Leukemia Treatment Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Chronic Myeloid Leukemia Treatment Forecast by Type

12.7 Global Chronic Myeloid Leukemia Treatment Forecast by Application

13 Key Players Analysis

13.1 Teva Pharmaceutical Industries Ltd

13.1.1 Teva Pharmaceutical Industries Ltd Company Information

13.1.2 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offered

13.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview

13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments

13.2 F. Hoffmann-La Roche Ltd.

13.2.1 F. Hoffmann-La Roche Ltd. Company Information

13.2.2 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offered

13.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.2.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.3 Novartis AG

13.3.1 Novartis AG Company Information

13.3.2 Novartis AG Chronic Myeloid Leukemia Treatment Product Offered

13.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis AG Main Business Overview

13.3.5 Novartis AG Latest Developments

13.4 Bristol-Myers Squibb Company

13.4.1 Bristol-Myers Squibb Company Company Information

13.4.2 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offered

13.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bristol-Myers Squibb Company Main Business Overview

13.4.5 Bristol-Myers Squibb Company Latest Developments

13.5 Pfizer Inc.

13.5.1 Pfizer Inc. Company Information

13.5.2 Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offered

13.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Inc. Main Business Overview

13.5.5 Pfizer Inc. Latest Developments

13.6 Takeda Pharmaceutical Company Limited

13.6.1 Takeda Pharmaceutical Company Limited Company Information

13.6.2 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offered

13.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.6.5 Takeda Pharmaceutical Company Limited Latest Developments

13.7 Innovent Biologics, Inc.

13.7.1 Innovent Biologics, Inc. Company Information

13.7.2 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offered

13.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Innovent Biologics, Inc. Main Business Overview

13.7.5 Innovent Biologics, Inc. Latest Developments

13.8 Viatris Inc. (Mylan N.V.)

13.8.1 Viatris Inc. (Mylan N.V.) Company Information

13.8.2 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offered

13.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Viatris Inc. (Mylan N.V.) Main Business Overview

13.8.5 Viatris Inc. (Mylan N.V.) Latest Developments

13.9 Lupin

13.9.1 Lupin Company Information

13.9.2 Lupin Chronic Myeloid Leukemia Treatment Product Offered

13.9.3 Lupin Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Lupin Main Business Overview

13.9.5 Lupin Latest Developments

13.10 IL-YANG PHARM CO. LTD.

13.10.1 IL-YANG PHARM CO. LTD. Company Information

13.10.2 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offered

13.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 IL-YANG PHARM CO. LTD. Main Business Overview

13.10.5 IL-YANG PHARM CO. LTD. Latest Developments

13.11 Million Health Pharmaceuticals

13.11.1 Million Health Pharmaceuticals Company Information

13.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offered

13.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Million Health Pharmaceuticals Main Business Overview

13.11.5 Million Health Pharmaceuticals Latest Developments

13.12 Celon Labs

13.12.1 Celon Labs Company Information

13.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Product Offered

13.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Celon Labs Main Business Overview

13.12.5 Celon Labs Latest Developments

14 Research Findings and Conclusion

Table 1. Chronic Myeloid Leukemia Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Chronic Myeloid Leukemia Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablet

Table 4. Major Players of Solution

Table 5. Major Players of Capsule

Table 6. Global Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)

Table 7. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

Table 8. Global Chronic Myeloid Leukemia Treatment Revenue by Type (2017-2022) & ($ million)

Table 9. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2017-2022)

Table 10. Global Chronic Myeloid Leukemia Treatment Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)

Table 12. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Table 13. Global Chronic Myeloid Leukemia Treatment Revenue by Application (2017-2022)

Table 14. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application (2017-2022)

Table 15. Global Chronic Myeloid Leukemia Treatment Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Chronic Myeloid Leukemia Treatment Sales by Company (2020-2022) & (K Units)

Table 17. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Company (2020-2022)

Table 18. Global Chronic Myeloid Leukemia Treatment Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company (2020-2022)

Table 20. Global Chronic Myeloid Leukemia Treatment Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Chronic Myeloid Leukemia Treatment Producing Area Distribution and Sales Area

Table 22. Players Chronic Myeloid Leukemia Treatment Products Offered

Table 23. Chronic Myeloid Leukemia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Chronic Myeloid Leukemia Treatment Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Chronic Myeloid Leukemia Treatment Sales Market Share Geographic Region (2017-2022)

Table 28. Global Chronic Myeloid Leukemia Treatment Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Chronic Myeloid Leukemia Treatment Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Country/Region (2017-2022)

Table 32. Global Chronic Myeloid Leukemia Treatment Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)

Table 35. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)

Table 36. Americas Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)

Table 38. Americas Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)

Table 39. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

Table 40. Americas Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)

Table 41. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Table 42. APAC Chronic Myeloid Leukemia Treatment Sales by Region (2017-2022) & (K Units)

Table 43. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2017-2022)

Table 44. APAC Chronic Myeloid Leukemia Treatment Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Chronic Myeloid Leukemia Treatment Revenue Market Share by Region (2017-2022)

Table 46. APAC Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)

Table 47. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

Table 48. APAC Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)

Table 49. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Table 50. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)

Table 51. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)

Table 52. Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)

Table 54. Europe Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)

Table 55. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

Table 56. Europe Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)

Table 57. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Chronic Myeloid Leukemia Treatment

Table 67. Key Market Challenges & Risks of Chronic Myeloid Leukemia Treatment

Table 68. Key Industry Trends of Chronic Myeloid Leukemia Treatment

Table 69. Chronic Myeloid Leukemia Treatment Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Chronic Myeloid Leukemia Treatment Distributors List

Table 72. Chronic Myeloid Leukemia Treatment Customer List

Table 73. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Chronic Myeloid Leukemia Treatment Sales Market Forecast by Region

Table 75. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Chronic Myeloid Leukemia Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Chronic Myeloid Leukemia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Chronic Myeloid Leukemia Treatment Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Chronic Myeloid Leukemia Treatment Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Chronic Myeloid Leukemia Treatment Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Chronic Myeloid Leukemia Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Chronic Myeloid Leukemia Treatment Revenue Market Share Forecast by Application (2023-2028)

Table 93. Teva Pharmaceutical Industries Ltd Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 94. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offered

Table 95. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Teva Pharmaceutical Industries Ltd Main Business

Table 97. Teva Pharmaceutical Industries Ltd Latest Developments

Table 98. F. Hoffmann-La Roche Ltd. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 99. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offered

Table 100. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. F. Hoffmann-La Roche Ltd. Main Business

Table 102. F. Hoffmann-La Roche Ltd. Latest Developments

Table 103. Novartis AG Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 104. Novartis AG Chronic Myeloid Leukemia Treatment Product Offered

Table 105. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Novartis AG Main Business

Table 107. Novartis AG Latest Developments

Table 108. Bristol-Myers Squibb Company Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 109. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offered

Table 110. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Bristol-Myers Squibb Company Main Business

Table 112. Bristol-Myers Squibb Company Latest Developments

Table 113. Pfizer Inc. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 114. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offered

Table 115. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Pfizer Inc. Main Business

Table 117. Pfizer Inc. Latest Developments

Table 118. Takeda Pharmaceutical Company Limited Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 119. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offered

Table 120. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Takeda Pharmaceutical Company Limited Main Business

Table 122. Takeda Pharmaceutical Company Limited Latest Developments

Table 123. Innovent Biologics, Inc. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 124. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offered

Table 125. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Innovent Biologics, Inc. Main Business

Table 127. Innovent Biologics, Inc. Latest Developments

Table 128. Viatris Inc. (Mylan N.V.) Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 129. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offered

Table 130. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Viatris Inc. (Mylan N.V.) Main Business

Table 132. Viatris Inc. (Mylan N.V.) Latest Developments

Table 133. Lupin Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 134. Lupin Chronic Myeloid Leukemia Treatment Product Offered

Table 135. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Lupin Main Business

Table 137. Lupin Latest Developments

Table 138. IL-YANG PHARM CO. LTD. Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 139. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offered

Table 140. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. IL-YANG PHARM CO. LTD. Main Business

Table 142. IL-YANG PHARM CO. LTD. Latest Developments

Table 143. Million Health Pharmaceuticals Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 144. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offered

Table 145. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Million Health Pharmaceuticals Main Business

Table 147. Million Health Pharmaceuticals Latest Developments

Table 148. Celon Labs Basic Information, Chronic Myeloid Leukemia Treatment Manufacturing Base, Sales Area and Its Competitors

Table 149. Celon Labs Chronic Myeloid Leukemia Treatment Product Offered

Table 150. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Celon Labs Main Business

Table 152. Celon Labs Latest Developments

List of Figures

Figure 1. Picture of Chronic Myeloid Leukemia Treatment

Figure 2. Chronic Myeloid Leukemia Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Chronic Myeloid Leukemia Treatment Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Chronic Myeloid Leukemia Treatment Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Chronic Myeloid Leukemia Treatment Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablet

Figure 10. Product Picture of Solution

Figure 11. Product Picture of Capsule

Figure 12. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type in 2021

Figure 13. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2017-2022)

Figure 14. Chronic Myeloid Leukemia Treatment Consumed in Hospital Pharmacies

Figure 15. Global Chronic Myeloid Leukemia Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 16. Chronic Myeloid Leukemia Treatment Consumed in Retail Pharmacies

Figure 17. Global Chronic Myeloid Leukemia Treatment Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 18. Chronic Myeloid Leukemia Treatment Consumed in Online Pharmacies

Figure 19. Global Chronic Myeloid Leukemia Treatment Market: Online Pharmacies (2017-2022) & (K Units)

Figure 20. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2017-2022)

Figure 21. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application in 2021

Figure 22. Chronic Myeloid Leukemia Treatment Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Company in 2021

Figure 24. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Geographic Region in 2021

Figure 26. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2017-2022)

Figure 27. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Country/Region in 2021

Figure 28. Americas Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)

Figure 29. Americas Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)

Figure 30. APAC Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)

Figure 31. APAC Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)

Figure 32. Europe Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)

Figure 33. Europe Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue 2017-2022 ($ Millions)

Figure 36. Americas Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021

Figure 37. Americas Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021

Figure 38. United States Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Chronic Myeloid Leukemia Treatment Sales Market Share by Region in 2021

Figure 43. APAC Chronic Myeloid Leukemia Treatment Revenue Market Share by Regions in 2021

Figure 44. China Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021

Figure 51. Europe Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021

Figure 52. Germany Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share by Country in 2021

Figure 59. Egypt Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Chronic Myeloid Leukemia Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Chronic Myeloid Leukemia Treatment in 2021

Figure 65. Manufacturing Process Analysis of Chronic Myeloid Leukemia Treatment

Figure 66. Industry Chain Structure of Chronic Myeloid Leukemia Treatment

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles